<DOC>
	<DOCNO>NCT01407965</DOCNO>
	<brief_summary>Tissue kinetics ertapenem meropenem fatty tissue , intraperitoneal fluid plasma .</brief_summary>
	<brief_title>Pharmacokinetics Carbapenem Antibiotics Obese Patients .</brief_title>
	<detailed_description>The purpose study determine free tissue kinetics ertapenem meropenem fatty tissue intraperitoneal fluid 24 hour administration IMP .</detailed_description>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<criteria>Hospitalized patient 18 year old require elective surgical intervention ( open laparoscopic surgery ) intraabdominal organ BMI even 40 write informed consent BMI &lt; 40 pregnancy lactation woman emergency surgery history serious allergy intolerance βlactam antibiotic systemic antimicrobial therapy ceftazidime ( internal standard highperformance liquid chromatography / mass spectrometry ) within 7 day period prior study entry ongoing intraabdominal infection terminal illness severe diseases liver , e.g . cirrhosis liver ALT AST &gt; 6 x upper limit normal ( ULN ) bilirubin &gt; 3 x ULN severe renal insufficiency creatinine clearance ≤30 mL/min . neutrophil count &lt; 1000 cells/mm3 platelet &lt; 75000 cells/mm3 coagulation study ( INR ) &gt; 1.5 x ULN ongoing chemotherapy and/or radiotherapy ongoing therapy valproin acid ( case ertapenem administration ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>obesity</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>ertapenem</keyword>
	<keyword>meropenem</keyword>
</DOC>